What is considered a “nucleotide” in a Sequence Listing XML?

According to MPEP 2412.03(d), a “nucleotide” in a Sequence Listing XML includes: Any nucleotide Nucleotide analogs Modified nucleotides The MPEP, citing WIPO Standard ST.26, specifies that a nucleotide must contain: A backbone moiety (e.g., 2′ deoxyribose 5′ monophosphate or an analogue) Either a nucleobase (including modified or synthetic purines or pyrimidines) or an “AP site”…

Read More

How does the MPEP address nucleotide analogs in its definition?

The MPEP 2412.03(d) includes nucleotide analogs in its comprehensive definition of nucleotides. Specifically, it states: “‘Nucleotide’ includes any nucleotide, nucleotide analog, or modified nucleotide as defined in paragraphs 3(f) and 3(g) of WIPO Standard ST.26.” The MPEP further elaborates on nucleotide analogs by describing backbone moieties that can be part of these structures: “an analogue…

Read More